Loading…

P-031 Idecabtagene vicleucel (ide-cel) vs standard regimens in patients with triple-class–exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 subgroup analysis by prior lines of therapy

Saved in:

Bibliographic Details
Published in:	Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2023-09, Vol.23, p.S50-S51
Main Authors:	Manier, Salomon, Rodriguez-Otero, Paula, Mateos, Maria-Victoria, Einsele, Hermann, Bahlis, Nizar, Munshi, Nikhil, Ailawadhi, Sikander, Arnulf, Bertrand, Nooka, Ajay, Vij, Ravi, Abrahamsen, Ingerid Weum, Broijl, Annemiek, Jagannath, Sundar, Benjamin, Reuben, Gergis, Usama, Sborov, Douglas, Iida, Shinsuke, Truppel-Hartmann, Anna, Yang, Zhihong, Bhatnagar, Rashmi, Piasecki, Julia, Felten, Jasper, Caia, Andrea, Cook, Mark, Baz, Rachid
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!